Inhibrx Biosciences shares owned by Vanguard Group
Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Inhibrx Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Inhibrx Biosciences held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibrx Biosciences by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $20M | 595k | 33.68 |
| 2025-06-30 | $8.5M | 598k | 14.27 |
| 2025-03-31 | $8.2M | 588k | 13.99 |
| 2024-12-31 | $9.4M | 608k | 15.40 |
| 2024-09-30 | $8.3M | 530k | 15.66 |
| 2024-06-30 | $6.8M | 478k | 14.17 |